chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 2/16/21, the morning after the vaccine I had a bad headache and spontaneous nose bleed. That evening I had upset stomach, exhaustion and loose stool. The next day, 2/17/21 I had headache all day and continued exhaustion. In the evening, I took my blood pressure and it was 156/98. An hour later, it was 165/98. By 9:30 p.m it had risen to 172/98 and I was shaking and having difficulty walking/talking.  I went to the emergency room. My blood pressure was still 172/98 upon arrival so blood work, EKG, chest X-ray, and CT scan were performed. I was released later that evening when my blood pressure came down to 156/98 . My normal blood pressure is always 120/80 or lower.
Within 5 min of injection: front 3rd top of tongue started getting numb and I got a metallic taste in mouth. That dissipated fairly quickly. Mostly gone within 30 min. Went home. Left side of Parotid started swelling - at 12/24/2020 in the morning. I didn't notice anything wrong until I tried to eat breakfast. Very painful. Swelled up very large. Couldnt' eat much for four days when I finally saw my dr (28th). and he gave  a prescription: an antibiotic and that started helping. When I  salivated it would start to swell. Pain was worse the first day and I massaged it alot to force saliva out of the grand. Tried to eat for very bland and very little on one side of mouth. Augmentin  Amox-Clad 875 mg. was the antibiotic I was given and that took about 24 hours to help.
Substernal chest pain a few hours after injection, lasting less than an hour. Patient does not recall much else as she reported this 3 months after incident.
shingles appeared on and around right thigh; pain in the right forearm; felt shoulder joint pain until now; This is a spontaneous report from a contactable consumer or other non hcp (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EW0170; Expiration date: not provided) via an unspecified route of administration on 16Apr2021 in left arm age at vaccination 53-year-old as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: ER8734; Expiration date: not provided) via an unspecified route of administration on 26Mar2021 in left arm age at vaccination 53-year-old as dose 1, single for Covid-19 immunization at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Apr2021, 10 days after vaccination, shingles appeared on and around right thigh. He visited urgent care for both arm pain and thigh pain after shingles pain appeared on 26Apr2021 and told the doctor he recently got COVID19 vaccine. The doctor said that the arm pain was due to the problem with my working gesture, like using computer for long time, so there was no treatment for the arm pain. The thigh pain was caused by the sciatic nerve, so no treatment for it either. Four days later he visited the urgent care/ emergency room again, and told the doctor that his thigh pain might be due to the shingles. An adverse events resulted into emergency room visit. Therapeutic measures were taken as a result of shingles appeared on and around right thigh, pain in the right forearm, and felt shoulder joint pain until now. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Pain and burning at site immediately after injection. Next day had redness, warmth, swelling at site with increased pain. I have continued shoulder pain that has not resolved since vaccination. I have no should medical history and never had musculoskeletal shoulder problems until receiving this injection.
Fever(101.2), 4 degrees above my normal(97.4).  Shaking chills. Generalized body aches, Fatigue, Slight Headache, Sore arm.  Refrained from Ibuprofen and Tylenol.  Rest. Fluids, All better in 48 hrs.
had genital herpetic reaction/ herpetic outbreak/rash; had genital herpetic reaction/ herpetic outbreak/rash; This is a spontaneous report received from contactable reporter(s) (Physician).  A 16-year-old female patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: GENITAL HERPES (non-serious), GENITAL RASH (non-serious), outcome "recovered" and all described as "had genital herpetic reaction/ herpetic outbreak/rash". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of genital herpes, genital rash.   Additional information: 16 year-old female patient received Comirnaty vaccine initial dosage and had genital herpetic reaction that was not reported as culture verified. Dermatologist reported full recovery of patient with "standard treatment". During medical conference, speaker/dermatologist reported herpetic outbreak/rash in 16 yo female patient after receiving covid 19 vaccine-Comirnaty. She reported no associated health problems or medications taken by the patient.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Flu vaccine given 10/14/16 at 19:00. That evening arm very sore by the next morning swollen and red. Pt given Ibuprofen and ice packs. 10/16/16 arm swollen down to elbow, bright and red. Taken to ER by parents.
Seriousness criteria other medically significant (OMIC). Initial report received on 10/10/06 from a health care professional. A 46 year old female pt, with a history of sinus problems, who takes Claritin and Zyrtec, had received a first, IM right deltoid dose of Typhim VI, lot number V0122-2, and a first , IM left deltoid dose of Twinrix, lot number AHABB068BB on 10/10/06 at 10:00am. At an specified amount of time later, on 10/10/06, the pt developed raspy breathing and flushing of her skin. Her blood pressure was 94/72 and heart rate was 150. The pt was transferred to the ER for further evaluation. Per the reporter, it was unknown what treatments, diagnostic testing or lab date were performed. At the time of this report, the recovery status of the pt was unk.
9:22 am tingling/itching of throat, followed by dizziness/generalized weakness and lightheadedness. Rapid HR and elevated BP .
Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles ) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history was  not reported).    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced HERPES ZOSTER (Shingles ). At the time of the report, HERPES ZOSTER (Shingles ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
inappropriately stored vaccine administered; This spontaneous report was received from a register nurse and refers to patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.   Since 28-JUL-2020, Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dosage regimen, route of administration, lot# and expiration date were not provided); and varicella virus vaccine live (oka/merck)(VARIVAX) (dosage regimen and route of administration were not reported) lot # T002843, expiration date 23-JAN-2022; and lot # S032357, expiration date 14-OCT-2021, experienced intermittent temperature excursion, but was not previously reported.  Then, on 14-AUG-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter (dosage regimen and route of administration were not reported) lot # T002843, expiration date 23-JAN-2022, as prophylaxis (product storage error). Nonetheless, it was not reported if the improperly stored doses of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) and varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S032357, expiration date 14-OCT-2021) were administered.  The improperly stored doses of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T002843, expiration date 23-JAN-2022; and lot # S032357, expiration date 14-OCT-2021) experienced a temperature of -14 degrees Celsius (°C) to -10°C (average maximus temperature was -9.5°C) for 38 hours and 30 minutes. No previous temperature excursion was reported. The call was made due to a digital data logger.; Sender's Comments:  US-009507513-2008USA014711: US-009507513-2008USA014701:
Received the second dose of her Pfizer COVID vaccine today when she started feeling hot and felt like her tongue was numb / swelling
pt recv vax;exp itch,pain,swelling & inflammation at inject site w/in 24 hrs;inflamed area was as large as a silver dollar coin;this is one of 11 patients who exp the above rxn p/vax
Information has been received from a licensed practical nurse (L.P.N.) concerning a 12 months old male patient with no pertinent medical history, drug reactions or allergies who on 06-MAY-2010 was vaccinated SQ in the left leg with a 0.5 mL dose of VARIVAX (Merck) (lot number 665886/1590Y). Concomitant therapy included MMR II administered in the right leg and PREVNAR administered in the left leg. Nurse reported that on 15-MAY-2010, the patient broke out with chickenpox on the left leg and at the injection site. By 19-MAY-2010, the patient had lots of chickenpox (full front, back, up on the neck and legs). At the time of reporting, the patient was recovering from the event. No laboratory diagnostic studies were performed. The patient sought medical attention, the patient visit the office. Follow up information has been received from the licensed practical nurse who reported that a male patient with esophageal reflux, and no illness at the time of vaccination, on 06-MAY-2010 was vaccinated with a first dose of VARIVAX (Merck) (Lot # 665886/1590Y), SQ in the left thigh at 17:00. The patient concomitantly received on the same day a first dose of MMR II (Lot # 664888/0765Y), and a first dose of PREVNAR (Lot # E44526), also at 17:00. On 17-MAY-2010 (previously reported as 15-MAY-2010) the patient was in office due to developing at the injection site area few isolated red spots in the periphery - few raised papules. On 19-MAY-2010 the patient back to office due to spreading - scattered erythematous small popular lesions. It was reported that the patient recovered on an unspecified date. Vaccine information statements (VIS) sheets were given to parents. Additional information is not expected.
Shot was given about 11am about 5:30 started to feel chilly, about 9:30 had chills, and at 11:30 developed fever of 101.8, very thirsty. I gave him 2 Tylenol and water, and sent him to bed. I will check him in about an hour or 2.  He gets a flu shot every year, this is the 1st time he ever had a reaction to it.
Severe pain in left hip, could not walk, was taken to ER in a wheel chair, was out of work for a week. Had an Epidural, pain lasted for 2 weeks before normal walk. Pt reported: I am a hospital employee. I have never  had a flu vaccine before. Since I am in contact with the public at the hospital my superiors insisted I have the vaccine. Since receiving the vaccine I have also had Bronchitis, which I have never had before. I never got a cold bad enough for me to miss work. Several other people at the hospital had similar problems.
Information has been received from a certified medical assistant concerning a female patient (age not reported) who on an unspecified date was vaccinated with Gardasil vaccine, 0.5 mL, in the gluteal muscle. Concomitant medication was not reported. On an unspecified date, the patient experienced swelling and redness at the site post vaccination. No other information was provided. The outcome of the events was not reported. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
first dose/3 years ago, never received the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 3 years ago on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were pro vided as follows: The age at vaccination was not applicable for this report. Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No vaccine details were available. The reporter consented to follow up.
Noticed colorless bumps after her 4 month dtap shot a week prior to adverse event. Then following week she got hib and polio on 4/9/12. The next morning on 4/10/11 he woke up with hives and inflamed  eczema where her colorless bumps were. She got hives after breast feeding. She now has a milk protein allergy. She was getting hives after I would eat cheese. This only started happening after the immunizations. She never had allergys before. I would eat cheese and drink milk all the time.
Patient developed a hot, raised, red rash that on her upper left arm, above her bicep muscle.
Bleeding noticed morning following vaccination, 12/18/2021. There was no gradual buildup, appeared on underwear. Pressure felt around navel has been consistent. Initially, dime sized clots showed in toilet when urinating. Clots have subsided since day 4, 12/21/2021. Lower back pain. Some cramping. Bleeding has necessitated pad change every 2-3 hours. Amount of flow has not changed since it first started, nor has it changed according to level of activity. Color is bright red. No noticeable fever.  On Thursday, 12/16/2021, an annual pelvic exam had been conducted. Contacted ob/gyn physician about bleeding,  BUT, DID NOT REVEAL  RECEIVING VACCINATION UNTIL 12/23/2021, BY EMAIL. Not until daughter shared that information that she had read concerning vaccine effects, did it be considered as possible factor in bleeding. That information was shared with patient on 12/23/2021, who then shared with VAERS and Dr., ob/gyn. An ultrasound had been ordered prior to report of vaccine to Dr.
He felt dizzy a 5 minutes after the vaccine and fell to the floor. Quickly recovered from unconsciousness.  Face is clammy and hands are cold.
This case was received from a health professional on 18 June 2009. A four-year-old male patient, with no reported medical history, received the following vaccinations on 05 June 2009: a fifth left leg injection of DAPTACEL (lot number C3082AA); a fourth left leg injection IPOL (lot number B1090-2); and a second left arm injection of MMR II (Merck, lot number 0423T). On 09 June 2009, four days post-vaccination, the patient developed swelling of the left upper leg from the front of his thigh to the back of the leg. The area was very reddened and painful. He was treated with an antibiotic and a three-day course of steroids. At the time of the report, there was a knot at the injection site. Patient outcome was reported as "unknown".
Airway edema; Lungs start feeling gooey and congested; Vocal chord swelling; Stuffy nose; Lost my voice; This is a spontaneous report from a contactable nurse (patient herself). A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm right on 19Mar2021 (Lot Number: ER8727) as single dose for covid-19 immunisation. Medical history included migraine diagnosed 30 years ago, cholesterol a little bit high diagnosed about 10 years ago, slightly high, patient didn't have to take statins or anything; reactive airway diagnosed at least 15 years ago. The was no concomitant medications. Patient received the first dose of the Pfizer Covid 19 vaccine on 19Mar2021. She had a history of being very reactive respiratory wise to irritants in the air. 45 minutes after first dose, patient experienced vocal chord swelling, stuffy nose, lost her voice, lungs start feeling gooey and congested on 19Mar2021. And 45 minutes after receiving the vaccine she had airway edema on 19Mar2021, which was not uncommon for her as she had a very reactive airway. The patient usually had airway edema when she was around any sort of latex, perfumes, chemicals, things like that. She took meds (levosalbutamol hydrochloride (XOPENEX), fluticasone propionate, salmeterol xinafoate (ADVAIR), levocetirizine dihydrochloride (XYZAL), diphenhydramine hydrochloride (BENADRYL), 5mg prednisone) immediately, inhalers and everything was fine 45 minutes to hour later. The airway edema subsided in 1.5 hours. She never went into respiratory distress. The patient took daily medications but declined to provide details on them, she did not believe this event was from them as she had been taking these medications for years. Reporter seriousness for airway edema was medically significant. Outcome of airway edema was recovered on 19Mar2021, and outcome of other events was recovered in Mar2021.; Sender's Comments: Based on a strong temporal relationship, A possible causal relationship between events Respiratory tract oedema, Pulmonary congestion, Vocal cord inflammation, Nasal congestion ,Aphonia and suspect drug BNT162B2 cannot be excluded    "The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate."
Patient was injected in her left deltoid and reported 10 minutes later swelling in her left arm and tingling down from the injection site to her finger tips.  I administered her a 25 mg benadryl and patient reported feeling better in less than 5 minutes.  Was determined that she experienced an adverse event not an allergic reaction as the benadryl would not have had time to work in the time it took for the swelling to subside.  Patient also reported after another 20 minutes that the tingling went away.
Two months old male a full term, previously healthy baby, presenting with pale and limp episodes x 2 for about 15-20 seconds and 10 second pt. was bradycardic after vaccination (about 10 minutes after vaccine). His eyes was open but kind of rolled up and partly bradycardic for 10-20 seconds. Pt. back to normal color and HR: 140, RR 24, no apnea, no cyanosis.
Incorrect route of product administration; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) tablet for CLL.    On an unknown date, the patient experienced NO ANTIBODIES AFTER COVID VACCINE.  COVID-19 VACCINE was also considered suspect.  Patient was not enrolled in a COVID-19 Vaccine Trial.  On unknown date, the patient received 1st dose COVID-19 Vaccine manufactured by Moderna, lot number unknown, expiration date unknown.  The patient's past medical history included Breast cancer. Concurrent medical conditions included High cholesterol and Low blood pressure. Concomitant products included CALCIUM CITRATE, DIMENHYDRINATE (DRAMAMINE), IRON, OMEPRAZOLE, PREDNISOLONE, PREDNISONE, SIMVASTATIN and PARACETAMOL (TYLENOL) for an unknown indication.   On 14-Sep-2020, the patient started IBRUTINIB (IMBRUVICA) (Oral) 420 mg. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) Antibody test negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) was unknown.       Adverse reaction: Antibody test Negative
temperature changes her ankles and lower calves get red marks; injection site reactions; Whenever I touch metal or cold my hands will turn bright red and it feels like they are on fire."/seems to be getting worse; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (temperature changes her ankles and lower calves get red marks), VACCINATION SITE REACTION (injection site reactions) and BURNING SENSATION (Whenever I touch metal or cold my hands will turn bright red and it feels like they are on fire."/seems to be getting worse) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 022C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced ERYTHEMA (temperature changes her ankles and lower calves get red marks), VACCINATION SITE REACTION (injection site reactions) and BURNING SENSATION (Whenever I touch metal or cold my hands will turn bright red and it feels like they are on fire."/seems to be getting worse). At the time of the report, ERYTHEMA (temperature changes her ankles and lower calves get red marks), VACCINATION SITE REACTION (injection site reactions) and BURNING SENSATION (Whenever I touch metal or cold my hands will turn bright red and it feels like they are on fire."/seems to be getting worse) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ERYTHEMA (temperature changes her ankles and lower calves get red marks), VACCINATION SITE REACTION (injection site reactions) and BURNING SENSATION (Whenever I touch metal or cold my hands will turn bright red and it feels like they are on fire."/seems to be getting worse) to be related.    Concomitant medications were not provided.  Treatment information was not provided.  Patient otherwise is healthy except the Covid time and did not take any medications and believes this reaction is related to the vaccine. The symptoms lasted for 3-4 days.   This case was linked to MOD-2021-404463 (Patient Link).